Search research articles
Contact Us
Filters
Showing results (121-130 of 214) with videos related to
Page
of 22
Sort By:
Pediatrics
|
April 4, 2007
Results of random drug testing in an adolescent substance abuse program
Sharon Levy, Lon Sherritt, Brigid L Vaughan, et al.
International Journal of Dermatology
|
May 1, 2004
Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea
Debra Breneman, Ronald Savin, Christine VandePol, et al.
Journal of Reproductive Immunology
|
December 30, 2006
Perfusion with lipopolysaccharide differently affects the secretion of tumor necrosis factor-alpha and interleukin-6 by term and preterm human placenta
Gershon Holcberg, Alaa Amash, Olga Sapir, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
September 19, 2022
Pediatric Subspecialist Alcohol Screening Rates and Concerns About Alcohol and Cannabis Use Among Their Adolescent Patients
Sharon Levy, Lauren E Wisk, Machiko Minegishi, et al.
Journal of Caffeine Research
|
January 13, 2017
Concurrent Validity of Caffeine Problems and Diagnostic Criteria for Substance Use Disorders
Elizabeth Harstad, Georgios Sideridis, Lon Sherritt, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
May 10, 2024
Identifying Adolescent Vaping With Screening to Brief Intervention and Brief Screener for Tobacco, Alcohol, and Drugs Screening Tools
Jennifer A Ross, Machiko Minegishi, Melissa Brogna, et al.
Journal of Drugs in Dermatology : JDD
|
February 2, 2011
Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream
C William Hanke, Neil Swanson, Suzanne Bruce, et al.
Journal of the American Academy of Dermatology
|
February 6, 2010
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles
Neil Swanson, William Abramovits, Brian Berman, et al.
Diseases of the Colon and Rectum
|
June 3, 2006
Long-term results of "chemical sphincterotomy" for chronic anal fissure: a prospective study
Joseph Lysy, Eran Israeli, Sharon Levy, et al.
Journal of Telemedicine and Telecare
|
September 10, 2002
Future patient care: tele-empowerment
Sharon Levy, David A Bradley, Moya J Morison, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 214) with videos related to
Sort By:
Page
of 22
Pediatrics
|
April 4, 2007
Results of random drug testing in an adolescent substance abuse program
Sharon Levy, Lon Sherritt, Brigid L Vaughan, et al.
International Journal of Dermatology
|
May 1, 2004
Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea
Debra Breneman, Ronald Savin, Christine VandePol, et al.
Journal of Reproductive Immunology
|
December 30, 2006
Perfusion with lipopolysaccharide differently affects the secretion of tumor necrosis factor-alpha and interleukin-6 by term and preterm human placenta
Gershon Holcberg, Alaa Amash, Olga Sapir, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
September 19, 2022
Pediatric Subspecialist Alcohol Screening Rates and Concerns About Alcohol and Cannabis Use Among Their Adolescent Patients
Sharon Levy, Lauren E Wisk, Machiko Minegishi, et al.
Journal of Caffeine Research
|
January 13, 2017
Concurrent Validity of Caffeine Problems and Diagnostic Criteria for Substance Use Disorders
Elizabeth Harstad, Georgios Sideridis, Lon Sherritt, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
May 10, 2024
Identifying Adolescent Vaping With Screening to Brief Intervention and Brief Screener for Tobacco, Alcohol, and Drugs Screening Tools
Jennifer A Ross, Machiko Minegishi, Melissa Brogna, et al.
Journal of Drugs in Dermatology : JDD
|
February 2, 2011
Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream
C William Hanke, Neil Swanson, Suzanne Bruce, et al.
Journal of the American Academy of Dermatology
|
February 6, 2010
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles
Neil Swanson, William Abramovits, Brian Berman, et al.
Diseases of the Colon and Rectum
|
June 3, 2006
Long-term results of "chemical sphincterotomy" for chronic anal fissure: a prospective study
Joseph Lysy, Eran Israeli, Sharon Levy, et al.
Journal of Telemedicine and Telecare
|
September 10, 2002
Future patient care: tele-empowerment
Sharon Levy, David A Bradley, Moya J Morison, et al.
Page
of 22